improving the specificity of molecular mrd detection
Published 5 years ago • 18 plays • Length 2:15Download video MP4
Download video MP3
Similar videos
-
1:40
updates on the use of molecular monitoring to detect mrd in aml
-
2:35
an update on mrd assessment and novel techniques used in the treatment of hematological malignancies
-
1:52
improving the use of mrd for the prognosis and treatment of all
-
2:03
prognostic significance of molecular mrd in npm1-mutated aml treated with venetoclax-based therapy
-
6:39
molecular techniques for monitoring mrd in aml
-
9:03
iccs education: minimal/measurable residual disease testing (mrd) by flow cytometry in bll
-
11:06
how could new treatment options improve outcomes in flt3-mutated aml?
-
28:19
diagnosis: morphology, flow cytometry, cytogenetics, molecular testing, and risk-stratification
-
2:07
using mrd to improve patient outcomes
-
0:46
the importance of mrd assessment in all phases of all treatment
-
2:05
using mrd negativity to measure depth of response & to discontinue treatment in multiple myeloma
-
1:05
the importance of using mrd to guide treatment decisions in all
-
2:23
the use of immunophenotyping to assess minimal residual disease (mrd) in multiple myeloma
-
2:25
master final analysis: quadruplet induction therapy, asct & mrd-adapted treatment cessation in ndmm
-
1:41
using cytogenetics to improve the diagnosis and prognosis of mds & to predict response to treatment
-
1:32
methods to evaluate mrd in aml
-
1:45
how should we utilizing molecular data to improve all treatment?
-
1:39
quantum-first: flt3-itd-specific mrd clearance is associated with improved os in newly diagnosed aml
-
4:22
the role of mrd in aml
-
1:25
using mrd to improve prognostication during the maintenance phase of myeloma treatment
-
2:22
improve study: mrd assessment as an endpoint to define treatment length and intensity in cll
-
3:23
molecular characteristics associated with increased risk of disease progression in smm